Clinical TrialsSearch results
Number of results: 701
Other
- Phase 3 Trial of Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
- Cervical cancer
- Deutsch Sonia
- 2021-08-06
Recruiting
- Phase 3 Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
- Locally advanced or metastatic non-squamous non-small cell lung cancer
- Imanishi Naoki
- 2023-06-03
Recruiting
- Phase 3 Study of Trastuzumab Deruxtecan as First-line Treatment of Unresectable, Locally Advanced, or Metastatic NSCLC Harboring HER2 Exon 19 or 20 Mutations (DESTINY-Lung04)
- NSCLC Harboring HER2 Exon 19 or 20 Mutations
- Inoguchi Akihiro
- 2021-12-23
Other
- Phase 3 study of pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma
- Endometrial cancer
- Hoki Toshifumi
- 2022-01-30
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Completed
- Phase 2 Dose-finding UC Study
- Ulcerative Colitis, Colitis, Ulcerative, IBD
- Ageishi Yuji
- 2021-08-30
Other
- Phase 1 trial of nivolumab and multisite radiotherapy for advanced gastric cancer (HGCSG2001)
- gastric cancer
- Komatsu Yoshito
- 2020-12-04